Tag: affordability

Politico Pro: Backlash builds over soaring drug prices

With a wave of new treatments carrying six-figure price tags in the pipeline, pressure is building on drugmakers to lower their prices, according to a new Politico Pro article. Continue reading

Posted in: Health Care Costs, Issue Alert

AHIP statement on Harvoni

America’s Health Insurance Plans (AHIP) Spokesman Brendan Buck released the following statement today after Gilead Sciences announced its newly approved hepatitis C drug Harvoni will be priced at $94,500 for a course of treatment. Continue reading

Posted in: Cost Alert, Health Care Costs

Any willing provider laws grab headlines in South Dakota

Any willing provider (AWP) laws – which allow any doctor or hospital to enter into a plan network – are making headlines thanks to a proposal on the ballot in South Dakota that would institute an AWP law and could prompt other states to consider similar policies. Continue reading

Posted in: Health Care Costs, Issue Alert

Chart of the day: Price matters

A new Morning Consult poll should serve as yet another a wake-up call for drugmakers, pushing them to be part of the solution to unaffordable and unsustainable prescription drugs. Continue reading

Posted in: Health Care Costs, Issue Alert

7 things we learned at the Health Affairs briefing on specialty drugs

Specialty drugs took center stage at today’s Health Affairs event, which introduced research from the October issue titled “Specialty Pharmaceutical Spending and Policy.” Below are some highlights. Continue reading

Posted in: Health Care Costs

NEWSFLASH: Many High-Price Drugs Are Covered the Same as a Hospital Visit

Why do you cover drugs so differently than a trip to the hospital? That’s the cry often heard from drugmakers as they try to defend the astronomical prices for some of their products. But it knowingly misleads from the fact that these high-priced drugs are often administered and paid for through health plan medical benefits. Continue reading

Posted in: Health Care Costs, Issue Alert

Moment of Truth: Gilead Comes to a Pricing Decision Point

The eyes of the health care world – and prime time TV audiences – are focused this week on the high prices of many pharmaceutical drugs. And one looming decision will tell us whether the tide has turned in favor of sustainable pricing – or whether drugmakers still have their heads in the sand. Continue reading

Posted in: Cost Alert, Health Care Costs

Small Business Owners Speak Out Against the HIT

This year alone, the health insurance tax (HIT) is expected to total roughly $8 billion, undermining the goal of affordability by increasing the cost of coverage for individuals, small businesses, seniors enrolled in Medicare Advantage, and states that rely on Medicaid health plans to provide high-quality care. In particular, small business owners across the country have expressed concern about the HIT and how it will affect their businesses and employees. Continue reading

Posted in: Health Care Costs, Issue Alert

AHIP’s Medicaid Conference tackles high-priced specialty drugs

Day one of AHIP’s Medicaid Conference featured a dynamic panel discussion that addressed the problem of rising prescription drug prices and the impact on access and innovation. Continue reading

Posted in: Health Care Costs

The dangers of AWP laws in 1-2-3

Health plans have been creating provider networks that deliver greater efficiency and higher quality. Three separate studies show that “any willing provider” (AWP) laws will undermine those efforts. 1. In the first report, Paul Ginsburg, the Norman Topping Chair in Medicine and Public Policy at the University of Southern California’s Schaeffer Center for Health Policy and Economics, concludes that AWP laws can increase health care costs and negatively affect care quality. AWP laws, which allow any doctor or hospital to [...]

Posted in: Health Care Costs, Issue Alert, Uncategorized